Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Drug-coated Balloon Angioplasty in Sri Lanka
Author(s): Yanushka Herath , Judy Ranaweera , Thisal Semina , et al Added: 1 week ago

Intervention

Prevention & Chronic Conditions
TCT 25: VICTORY Trial: Intravascular Lithotripsy vs Super-High-Pressure Balloons for Calcified Coronary Lesions
Author(s): Matthias Bossard Added: 1 month ago
TCT 2025 - The randomized VICTORY Study finds OCT-guided PCI involving lesion preparation with the OPN super-high-pressure non-compliant balloon is non-inferior to intravascular lithotropsy.Dr Matthias Bossard (Kantonsspital Lucerne, Lucerne, CH) joins us to discuss findings from the VICTORY Trial, a randomized, multicenter, non-inferiority comparison evaluating intravascular lithotripsy versus… View more

Intervention

MI/ACS
TCT 2025: Short-CUT: Lithotripsy Vs Cutting Balloon for CAD
Author(s): Suzanne J Baron Added: 1 month ago
TCT 2025 — Dr Suzanne J Baron (Massachusetts General Hospital, US), principal investigator of the Short-CUT trial (NCT06089135; Baim Institute for Clinical Research), joins us to discuss this investigator-initiated, multicentre randomized controlled study.The trial enrolled 410 patients with moderate to severe coronary artery calcification across up to 22 international sites. Eligible… View more

Intervention
Drug-eluting Balloons: Experience from Central India
Author(s): Ajinkya Mahorkar , Virag Mahorkar , Uday Mahorkar , et al Added: 8 months ago

Intervention

Prevention & Chronic Conditions
HFA 24: Timing of Cardio-Kidney Protection with SGLT2i
Author(s): Muthiah Vaduganathan Added: 1 year ago
HFA 24 - We are joined by Dr Muthiah Vaduganathan (Brigham and Women’s Hospital, US) to discuss the findings from a study of four large-scale placebo controlled-trials investigating the timing of cardio-kidney protection with SGLT2 inhibitors.4 trials that sampled distinct patient populations were enrolled in the trial - the CANVAS program, the CREDENCE trial, DAPA-HF and DELIVER. Across each… View more

Heart Failure

Prevention & Chronic Conditions
Author(s): Owais Dar , Espeed Khoshbin Added: 1 year ago
Heart transplantation and left ventricular assist devices (LVADs) are crucial options for patients with advanced heart failure, but determining the right timing for intervention is key to optimizing outcomes. This webinar, moderated by Dr Owais Dar from the Royal Brompton and Harefield Hospitals, will explore the decision-making process behind patient referrals, weighing the benefits and risks of… View more

Heart Failure
Timing of Heart Transplantation & LVADs
Author(s): Espeed Khoshbin , Owais Dar Start date: Nov 05, 2024
Heart transplantation and left ventricular assist devices (LVADs) are crucial options for patients with advanced heart failure, but determining the right timing for intervention is key to optimizing outcomes. This webinar, moderated by Dr Owais Dar from the Royal Brompton and Harefield Hospitals, will explore the decision-making process behind patient referrals, weighing the benefits and risks of… View more

Heart Failure
Balloon-expandable versus Self-expanding Valves
Author(s): Jie Jun Wong , Eugene Gan , Fei Gao , et al Added: 2 years ago

Intervention

Vascular Disease and Surgery
TCT 2025: SELUTION DeNovo: 1-Year Results Comparing Sirolimus Balloon vs DES in PCI
Author(s): Christian Spaulding Added: 1 month ago
TCT 2025 — Prof Christian M Spaulding (European Hospital Georges Pompidou & INSERM U 970, FR), principal investigator of the SELUTION DeNovo trial (M.A. Med Alliance S.A.; NCT04859985), joins us to share the one year results.This international, multicentre randomised trial enrolled over 3,300 patients at 50 sites across Europe and Asia to compare a sirolimus-eluting balloon (SEB) plus provisional… View more

Intervention
Acute Coronary Syndrome Post-TAVR with Dr Samineh Sehatbakhsh
Author(s): Samineh Sehatbakhsh Added: 3 months ago
Navigate the complex landscape of coronary interventions following transcatheter aortic valve replacement with Dr Samineh Sehatbakhsh, addressing critical access challenges in an era of expanding TAVR indications.This essential presentation, part of the Complex Cases track, examines the growing clinical significance of post-TAVR coronary access as procedures expand to younger, lower-risk patients… View more

Intervention